Home > > > Report Detail

COVID-19 Outbreak-Global Nuclear Medicine or Radiopharmaceuticals Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

Publisher Name :
Date: 12-Jun-2020
No. of pages: 127

Nuclear Medicine & Radiopharmaceuticals. Nuclear medicine is a medical specialty which uses radioactive tracers (radiopharmaceuticals) to diagnose and treat disease. Specially designed cameras allow doctors to track the circulation, uptake and excretion of these radioactive tracers.

The Nuclear Medicine or Radiopharmaceuticals market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.

Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.

In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Nuclear Medicine or Radiopharmaceuticals industry.

Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.

In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.

The Nuclear Medicine or Radiopharmaceuticals market can be split based on product types, major applications, and important countries as follows:

Key players in the global Nuclear Medicine or Radiopharmaceuticals market covered in Chapter 12:

Cardinal Health

GE Healthcare

Bayer Healthcare

Mallinckrodt PLC

Nordion

Lantheus Medical Imaging

Advanced Accelerator Applications S.A.

Eczcibasi-Monrol Nuclear Products

Bracco Imaging S.P.A

IBA Molecular Imaging

In Chapter 4 and 14.1, on the basis of types, the Nuclear Medicine or Radiopharmaceuticals market from 2015 to 2025 is primarily split into:

Diagnosis

Therapeutics

In Chapter 5 and 14.2, on the basis of applications, the Nuclear Medicine or Radiopharmaceuticals market from 2015 to 2025 covers:

Alpha radiation therapy

Beta radiation therapy

Brachytherapy

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:

North America (Covered in Chapter 7 and 14)

United States

Canada

Mexico

Europe (Covered in Chapter 8 and 14)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 9 and 14)

China

Japan

South Korea

Australia

India

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 10 and 14)

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Others

South America (Covered in Chapter 11 and 14)

Brazil

Argentina

Columbia

Chile

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2025

COVID-19 Outbreak-Global Nuclear Medicine or Radiopharmaceuticals Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

Table of Content

1 Nuclear Medicine or Radiopharmaceuticals Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Nuclear Medicine or Radiopharmaceuticals
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Nuclear Medicine or Radiopharmaceuticals industry
1.4 Methodology of The Study
1.5 Research Data Source

2 Executive Summary
2.1 Market Overview
2.1.1 Global Nuclear Medicine or Radiopharmaceuticals Market Size, 2015 - 2020
2.1.2 Global Nuclear Medicine or Radiopharmaceuticals Market Size by Type, 2015 - 2020
2.1.3 Global Nuclear Medicine or Radiopharmaceuticals Market Size by Application, 2015 - 2020
2.1.4 Global Nuclear Medicine or Radiopharmaceuticals Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Nuclear Medicine or Radiopharmaceuticals Industry Development

3 Industry Chain Analysis
3.1 Upstream Raw Material Suppliers of Nuclear Medicine or Radiopharmaceuticals Analysis
3.2 Major Players of Nuclear Medicine or Radiopharmaceuticals
3.3 Nuclear Medicine or Radiopharmaceuticals Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Nuclear Medicine or Radiopharmaceuticals
3.3.3 Labor Cost of Nuclear Medicine or Radiopharmaceuticals
3.4 Market Distributors of Nuclear Medicine or Radiopharmaceuticals
3.5 Major Downstream Buyers of Nuclear Medicine or Radiopharmaceuticals Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally

4 Global Nuclear Medicine or Radiopharmaceuticals Market, by Type
4.1 Global Nuclear Medicine or Radiopharmaceuticals Value and Market Share by Type (2015-2020)
4.2 Global Nuclear Medicine or Radiopharmaceuticals Production and Market Share by Type (2015-2020)
4.3 Global Nuclear Medicine or Radiopharmaceuticals Value and Growth Rate by Type (2015-2020)
4.3.1 Global Nuclear Medicine or Radiopharmaceuticals Value and Growth Rate of Diagnosis
4.3.2 Global Nuclear Medicine or Radiopharmaceuticals Value and Growth Rate of Therapeutics
4.4 Global Nuclear Medicine or Radiopharmaceuticals Price Analysis by Type (2015-2020)

5 Nuclear Medicine or Radiopharmaceuticals Market, by Application
5.1 Downstream Market Overview
5.2 Global Nuclear Medicine or Radiopharmaceuticals Consumption and Market Share by Application (2015-2020)
5.3 Global Nuclear Medicine or Radiopharmaceuticals Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Nuclear Medicine or Radiopharmaceuticals Consumption and Growth Rate of Alpha radiation therapy (2015-2020)
5.3.2 Global Nuclear Medicine or Radiopharmaceuticals Consumption and Growth Rate of Beta radiation therapy (2015-2020)
5.3.3 Global Nuclear Medicine or Radiopharmaceuticals Consumption and Growth Rate of Brachytherapy (2015-2020)

6 Global Nuclear Medicine or Radiopharmaceuticals Market Analysis by Regions
6.1 Global Nuclear Medicine or Radiopharmaceuticals Sales, Revenue and Market Share by Regions
6.1.1 Global Nuclear Medicine or Radiopharmaceuticals Sales by Regions (2015-2020)
6.1.2 Global Nuclear Medicine or Radiopharmaceuticals Revenue by Regions (2015-2020)
6.2 North America Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6.3 Europe Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6.6 South America Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

7 North America Nuclear Medicine or Radiopharmaceuticals Market Analysis by Countries
7.1 The Influence of COVID-19 on North America Market
7.2 North America Nuclear Medicine or Radiopharmaceuticals Sales, Revenue and Market Share by Countries
7.2.1 North America Nuclear Medicine or Radiopharmaceuticals Sales by Countries (2015-2020)
7.2.2 North America Nuclear Medicine or Radiopharmaceuticals Revenue by Countries (2015-2020)
7.3 United States Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.4 Canada Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.5 Mexico Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

8 Europe Nuclear Medicine or Radiopharmaceuticals Market Analysis by Countries
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Nuclear Medicine or Radiopharmaceuticals Sales, Revenue and Market Share by Countries
8.2.1 Europe Nuclear Medicine or Radiopharmaceuticals Sales by Countries (2015-2020)
8.2.2 Europe Nuclear Medicine or Radiopharmaceuticals Revenue by Countries (2015-2020)
8.3 Germany Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
8.4 UK Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
8.5 France Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
8.6 Italy Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
8.7 Spain Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
8.8 Russia Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

9 Asia Pacific Nuclear Medicine or Radiopharmaceuticals Market Analysis by Countries
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Nuclear Medicine or Radiopharmaceuticals Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Nuclear Medicine or Radiopharmaceuticals Sales by Countries (2015-2020)
9.2.2 Asia Pacific Nuclear Medicine or Radiopharmaceuticals Revenue by Countries (2015-2020)
9.3 China Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9.4 Japan Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9.5 South Korea Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9.6 India Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9.8 Australia Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

10 Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Market Analysis by Countries
10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Revenue by Countries (2015-2020)
10.3 Saudi Arabia Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
10.4 UAE Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
10.5 Egypt Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
10.6 Nigeria Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
10.7 South Africa Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

11 South America Nuclear Medicine or Radiopharmaceuticals Market Analysis by Countries
11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Nuclear Medicine or Radiopharmaceuticals Sales, Revenue and Market Share by Countries
11.2.1 South America Nuclear Medicine or Radiopharmaceuticals Sales by Countries (2015-2020)
11.2.2 South America Nuclear Medicine or Radiopharmaceuticals Revenue by Countries (2015-2020)
11.3 Brazil Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
11.4 Argentina Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
11.5 Columbia Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
11.6 Chile Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

12 Competitive Landscape
12.1 Cardinal Health
12.1.1 Cardinal Health Basic Information
12.1.2 Nuclear Medicine or Radiopharmaceuticals Product Introduction
12.1.3 Cardinal Health Production, Value, Price, Gross Margin 2015-2020
12.2 GE Healthcare
12.2.1 GE Healthcare Basic Information
12.2.2 Nuclear Medicine or Radiopharmaceuticals Product Introduction
12.2.3 GE Healthcare Production, Value, Price, Gross Margin 2015-2020
12.3 Bayer Healthcare
12.3.1 Bayer Healthcare Basic Information
12.3.2 Nuclear Medicine or Radiopharmaceuticals Product Introduction
12.3.3 Bayer Healthcare Production, Value, Price, Gross Margin 2015-2020
12.4 Mallinckrodt PLC
12.4.1 Mallinckrodt PLC Basic Information
12.4.2 Nuclear Medicine or Radiopharmaceuticals Product Introduction
12.4.3 Mallinckrodt PLC Production, Value, Price, Gross Margin 2015-2020
12.5 Nordion
12.5.1 Nordion Basic Information
12.5.2 Nuclear Medicine or Radiopharmaceuticals Product Introduction
12.5.3 Nordion Production, Value, Price, Gross Margin 2015-2020
12.6 Lantheus Medical Imaging
12.6.1 Lantheus Medical Imaging Basic Information
12.6.2 Nuclear Medicine or Radiopharmaceuticals Product Introduction
12.6.3 Lantheus Medical Imaging Production, Value, Price, Gross Margin 2015-2020
12.7 Advanced Accelerator Applications S.A.
12.7.1 Advanced Accelerator Applications S.A. Basic Information
12.7.2 Nuclear Medicine or Radiopharmaceuticals Product Introduction
12.7.3 Advanced Accelerator Applications S.A. Production, Value, Price, Gross Margin 2015-2020
12.8 Eczcibasi-Monrol Nuclear Products
12.8.1 Eczcibasi-Monrol Nuclear Products Basic Information
12.8.2 Nuclear Medicine or Radiopharmaceuticals Product Introduction
12.8.3 Eczcibasi-Monrol Nuclear Products Production, Value, Price, Gross Margin 2015-2020
12.9 Bracco Imaging S.P.A
12.9.1 Bracco Imaging S.P.A Basic Information
12.9.2 Nuclear Medicine or Radiopharmaceuticals Product Introduction
12.9.3 Bracco Imaging S.P.A Production, Value, Price, Gross Margin 2015-2020
12.10 IBA Molecular Imaging
12.10.1 IBA Molecular Imaging Basic Information
12.10.2 Nuclear Medicine or Radiopharmaceuticals Product Introduction
12.10.3 IBA Molecular Imaging Production, Value, Price, Gross Margin 2015-2020

13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release

14 Global Nuclear Medicine or Radiopharmaceuticals Market Forecast
14.1 Global Nuclear Medicine or Radiopharmaceuticals Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Diagnosis Market Value and Volume Forecast (2020-2025)
14.1.2 Therapeutics Market Value and Volume Forecast (2020-2025)
14.2 Global Nuclear Medicine or Radiopharmaceuticals Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Alpha radiation therapy Market Value and Volume Forecast (2020-2025)
14.2.2 Beta radiation therapy Market Value and Volume Forecast (2020-2025)
14.2.3 Brachytherapy Market Value and Volume Forecast (2020-2025)
14.3 Nuclear Medicine or Radiopharmaceuticals Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)

15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter's Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
?
List of Tables and Figures

Figure Product Picture of Nuclear Medicine or Radiopharmaceuticals
Table Product Specification of Nuclear Medicine or Radiopharmaceuticals
Table Nuclear Medicine or Radiopharmaceuticals Key Market Segments
Table Key Players Nuclear Medicine or Radiopharmaceuticals Covered
Figure Global Nuclear Medicine or Radiopharmaceuticals Market Size, 2015 - 2025
Table Different Types of Nuclear Medicine or Radiopharmaceuticals
Figure Global Nuclear Medicine or Radiopharmaceuticals Value ($) Segment by Type from 2015-2020
Figure Global Nuclear Medicine or Radiopharmaceuticals Market Share by Types in 2019
Table Different Applications of Nuclear Medicine or Radiopharmaceuticals
Figure Global Nuclear Medicine or Radiopharmaceuticals Value ($) Segment by Applications from 2015-2020
Figure Global Nuclear Medicine or Radiopharmaceuticals Market Share by Applications in 2019
Figure Global Nuclear Medicine or Radiopharmaceuticals Market Share by Regions in 2019
Figure North America Nuclear Medicine or Radiopharmaceuticals Production Value ($) and Growth Rate (2015-2020)
Figure Europe Nuclear Medicine or Radiopharmaceuticals Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Nuclear Medicine or Radiopharmaceuticals Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Production Value ($) and Growth Rate (2015-2020)
Figure South America Nuclear Medicine or Radiopharmaceuticals Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Nuclear Medicine or Radiopharmaceuticals
Table Upstream Raw Material Suppliers of Nuclear Medicine or Radiopharmaceuticals with Contact Information
Table Major Players Headquarters, and Service Area of Nuclear Medicine or Radiopharmaceuticals
Figure Major Players Production Value Market Share of Nuclear Medicine or Radiopharmaceuticals in 2019
Table Major Players Nuclear Medicine or Radiopharmaceuticals Product Types in 2019
Figure Production Process of Nuclear Medicine or Radiopharmaceuticals
Figure Manufacturing Cost Structure of Nuclear Medicine or Radiopharmaceuticals
Figure Channel Status of Nuclear Medicine or Radiopharmaceuticals
Table Major Distributors of Nuclear Medicine or Radiopharmaceuticals with Contact Information
Table Major Downstream Buyers of Nuclear Medicine or Radiopharmaceuticals with Contact Information
Table Global Nuclear Medicine or Radiopharmaceuticals Value ($) by Type (2015-2020)
Table Global Nuclear Medicine or Radiopharmaceuticals Value Share by Type (2015-2020)
Figure Global Nuclear Medicine or Radiopharmaceuticals Value Share by Type (2015-2020)
Table Global Nuclear Medicine or Radiopharmaceuticals Production by Type (2015-2020)
Table Global Nuclear Medicine or Radiopharmaceuticals Production Share by Type (2015-2020)
Figure Global Nuclear Medicine or Radiopharmaceuticals Production Share by Type (2015-2020)
Figure Global Nuclear Medicine or Radiopharmaceuticals Value ($) and Growth Rate of Diagnosis (2015-2020)
Figure Global Nuclear Medicine or Radiopharmaceuticals Value ($) and Growth Rate of Therapeutics (2015-2020)
Figure Global Nuclear Medicine or Radiopharmaceuticals Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Nuclear Medicine or Radiopharmaceuticals Consumption by Application (2015-2020)
Table Global Nuclear Medicine or Radiopharmaceuticals Consumption Market Share by Application (2015-2020)
Figure Global Nuclear Medicine or Radiopharmaceuticals Consumption Market Share by Application (2015-2020)
Figure Global Nuclear Medicine or Radiopharmaceuticals Consumption and Growth Rate of Alpha radiation therapy (2015-2020)
Figure Global Nuclear Medicine or Radiopharmaceuticals Consumption and Growth Rate of Beta radiation therapy (2015-2020)
Figure Global Nuclear Medicine or Radiopharmaceuticals Consumption and Growth Rate of Brachytherapy (2015-2020)
Figure Global Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (M USD) and Growth (2015-2020)
Table Global Nuclear Medicine or Radiopharmaceuticals Sales by Regions (2015-2020)
Table Global Nuclear Medicine or Radiopharmaceuticals Sales Market Share by Regions (2015-2020)
Table Global Nuclear Medicine or Radiopharmaceuticals Revenue (M USD) by Regions (2015-2020)
Table Global Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Regions (2015-2020)
Table Global Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Regions in 2015
Table Global Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Regions in 2019
Figure North America Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Europe Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure South America Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Nuclear Medicine or Radiopharmaceuticals Revenue (M USD) and Growth (2015-2020)
Table North America Nuclear Medicine or Radiopharmaceuticals Sales by Countries (2015-2020)
Table North America Nuclear Medicine or Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table North America Nuclear Medicine or Radiopharmaceuticals Revenue (M USD) by Countries (2015-2020)
Table North America Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure United States Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Canada Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Mexico Nuclear Medicine or Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Nuclear Medicine or Radiopharmaceuticals Revenue (M USD) and Growth (2015-2020)
Table Europe Nuclear Medicine or Radiopharmaceuticals Sales by Countries (2015-2020)
Table Europe Nuclear Medicine or Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table Europe Nuclear Medicine or Radiopharmaceuticals Revenue (M USD) by Countries (2015-2020)
Table Europe Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure Germany Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure UK Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure France Nuclear Medicine or Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Italy Nuclear Medicine or Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Spain Nuclear Medicine or Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Russia Nuclear Medicine or Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Nuclear Medicine or Radiopharmaceuticals Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Nuclear Medicine or Radiopharmaceuticals Sales by Countries (2015-2020)
Table Asia Pacific Nuclear Medicine or Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table Asia Pacific Nuclear Medicine or Radiopharmaceuticals Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure China Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Japan Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure South Korea Nuclear Medicine or Radiopharmaceuticals Sales and Growth (2015-2020)
Figure India Nuclear Medicine or Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Southeast Asia Nuclear Medicine or Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Australia Nuclear Medicine or Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Middle East Nuclear Medicine or Radiopharmaceuticals Revenue (M USD) and Growth (2015-2020)
Table Middle East Nuclear Medicine or Radiopharmaceuticals Sales by Countries (2015-2020)
Table Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure UAE Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Egypt Nuclear Medicine or Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Nigeria Nuclear Medicine or Radiopharmaceuticals Sales and Growth (2015-2020)
Figure South Africa Nuclear Medicine or Radiopharmaceuticals Sales and Growth (2015-2020)
Figure South America Nuclear Medicine or Radiopharmaceuticals Revenue (M USD) and Growth (2015-2020)
Table South America Nuclear Medicine or Radiopharmaceuticals Sales by Countries (2015-2020)
Table South America Nuclear Medicine or Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table South America Nuclear Medicine or Radiopharmaceuticals Revenue (M USD) by Countries (2015-2020)
Table South America Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure Brazil Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Argentina Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Columbia Nuclear Medicine or Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Chile Nuclear Medicine or Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Top 3 Market Share of Nuclear Medicine or Radiopharmaceuticals Companies in 2019
Figure Top 6 Market Share of Nuclear Medicine or Radiopharmaceuticals Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Cardinal Health Profile
Table Cardinal Health Product Introduction
Figure Cardinal Health Production and Growth Rate
Figure Cardinal Health Value ($) Market Share 2015-2020
Table GE Healthcare Profile
Table GE Healthcare Product Introduction
Figure GE Healthcare Production and Growth Rate
Figure GE Healthcare Value ($) Market Share 2015-2020
Table Bayer Healthcare Profile
Table Bayer Healthcare Product Introduction
Figure Bayer Healthcare Production and Growth Rate
Figure Bayer Healthcare Value ($) Market Share 2015-2020
Table Mallinckrodt PLC Profile
Table Mallinckrodt PLC Product Introduction
Figure Mallinckrodt PLC Production and Growth Rate
Figure Mallinckrodt PLC Value ($) Market Share 2015-2020
Table Nordion Profile
Table Nordion Product Introduction
Figure Nordion Production and Growth Rate
Figure Nordion Value ($) Market Share 2015-2020
Table Lantheus Medical Imaging Profile
Table Lantheus Medical Imaging Product Introduction
Figure Lantheus Medical Imaging Production and Growth Rate
Figure Lantheus Medical Imaging Value ($) Market Share 2015-2020
Table Advanced Accelerator Applications S.A. Profile
Table Advanced Accelerator Applications S.A. Product Introduction
Figure Advanced Accelerator Applications S.A. Production and Growth Rate
Figure Advanced Accelerator Applications S.A. Value ($) Market Share 2015-2020
Table Eczcibasi-Monrol Nuclear Products Profile
Table Eczcibasi-Monrol Nuclear Products Product Introduction
Figure Eczcibasi-Monrol Nuclear Products Production and Growth Rate
Figure Eczcibasi-Monrol Nuclear Products Value ($) Market Share 2015-2020
Table Bracco Imaging S.P.A Profile
Table Bracco Imaging S.P.A Product Introduction
Figure Bracco Imaging S.P.A Production and Growth Rate
Figure Bracco Imaging S.P.A Value ($) Market Share 2015-2020
Table IBA Molecular Imaging Profile
Table IBA Molecular Imaging Product Introduction
Figure IBA Molecular Imaging Production and Growth Rate
Figure IBA Molecular Imaging Value ($) Market Share 2015-2020
Table Market Driving Factors of Nuclear Medicine or Radiopharmaceuticals
Table Merger, Acquisition and New Investment
Table Global Nuclear Medicine or Radiopharmaceuticals Market Value ($) Forecast, by Type
Table Global Nuclear Medicine or Radiopharmaceuticals Market Volume Forecast, by Type
Figure Global Nuclear Medicine or Radiopharmaceuticals Market Value ($) and Growth Rate Forecast of Diagnosis (2020-2025)
Figure Global Nuclear Medicine or Radiopharmaceuticals Market Volume ($) and Growth Rate Forecast of Diagnosis (2020-2025)
Figure Global Nuclear Medicine or Radiopharmaceuticals Market Value ($) and Growth Rate Forecast of Therapeutics (2020-2025)
Figure Global Nuclear Medicine or Radiopharmaceuticals Market Volume ($) and Growth Rate Forecast of Therapeutics (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Alpha radiation therapy (2020-2025)
Figure Market Volume and Growth Rate Forecast of Alpha radiation therapy (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Beta radiation therapy (2020-2025)
Figure Market Volume and Growth Rate Forecast of Beta radiation therapy (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Brachytherapy (2020-2025)
Figure Market Volume and Growth Rate Forecast of Brachytherapy (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter's Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs